Christopher McCann
Publications by Year
Research Areas
Cell death mechanisms and regulation, Ovarian cancer diagnosis and treatment, Cancer-related Molecular Pathways, Endometrial and Cervical Cancer Treatments, Uterine Myomas and Treatments
Most-Cited Works
- → Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model(2011)89 cited
- Surgical debulking of ovarian cancer: what difference does it make?(2010)
- → Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy(2018)69 cited
- → A revised model of TRAIL ‐R2 DISC assembly explains how FLIP (L) can inhibit or promote apoptosis(2020)56 cited
- → Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma(2010)46 cited
- Laparoscopic surgical staging of early ovarian cancer.(2011)
- → PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy(2016)40 cited
- → Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer(2011)34 cited
- → Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer(2021)27 cited
- → Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant(2020)26 cited